Product Recalls in Colorado

Product recalls affecting Colorado — including food, drugs, consumer products, medical devices, and vehicles distributed to Colorado. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,724 recalls have been distributed to Colorado in the last 12 months.

51,434 total recalls
2,724 in last 12 months

Showing 461480 of 13,494 recalls

DrugJuly 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Fluorescein 2% Ophth Recalled by Boothwyn Pharmacy LLC Due to Subpotent Drug

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Semaglutide Recalled by Boothwyn Pharmacy LLC Due to Subpotent Drug

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 9, 2025· Boothwyn Pharmacy LLC

Recalled Item: Semaglutide Recalled by Boothwyn Pharmacy LLC Due to Subpotent Drug

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 9, 2025· Strides Pharma, Inc.

Recalled Item: Cinacalcet Tablets 90 mg Recalled by Strides Pharma, Inc. Due to Failed...

The Issue: Failed Dissolution Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 9, 2025· Imprimis NJOF, LLC

Recalled Item: Tropicamide-Proparacaine-Phenylephrine-Ketorolac Recalled by Imprimis NJOF,...

The Issue: Sub-Potent Drug: Subpotent assay results during stability testing.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 9, 2025· Imprimis NJOF, LLC

Recalled Item: Epinephrine Lidocaine HCL Recalled by Imprimis NJOF, LLC Due to Sub-Potent...

The Issue: Sub-Potent Drug: Subpotent assay results during stability testing.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 9, 2025· Ascend Laboratories, LLC

Recalled Item: Rizatriptan Benzoate Tablets Recalled by Ascend Laboratories, LLC Due to...

The Issue: CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 9, 2025· Ascend Laboratories, LLC

Recalled Item: Rizatriptan Benzoate Tablets Recalled by Ascend Laboratories, LLC Due to...

The Issue: CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: Good Neighbor Pharmacy Recalled by MEDLINE INDUSTRIES, LP - Northfield Due...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: CURAD Alcohol Prep Pads Recalled by MEDLINE INDUSTRIES, LP - Northfield Due...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: ReliOn Recalled by MEDLINE INDUSTRIES, LP - Northfield Due to Subpotent...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: Medline Alcohol Prep Pads Recalled by MEDLINE INDUSTRIES, LP - Northfield...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: RITE AID PHARMACY Recalled by MEDLINE INDUSTRIES, LP - Northfield Due to...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 7, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: H-E-B Recalled by MEDLINE INDUSTRIES, LP - Northfield Due to Subpotent Drug-...

The Issue: Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 5, 2025· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP Recalled by FDC Limited Due to...

The Issue: Defective Container: spike of the cap becomes lodged in the nozzle of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 2, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg Recalled by Lupin...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Cipla USA, Inc.

Recalled Item: Budesonide Inhalation Suspension Recalled by Cipla USA, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: A market complaint was received for leakage...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Omeprazole Delayed-release Capsules Recalled by Dr. Reddy's Laboratories,...

The Issue: Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 30, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 27, 2025· Lupin Pharmaceuticals Inc.

Recalled Item: clomiPRAMINE Hydrochloride Capsules USP 25 mg Recalled by Lupin...

The Issue: Failed Impurities/Degradation Specifications: an out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund